- Home
- KMDA vs SENS Comparison
KMDA vs SENS Comparison
Compare KMDA & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- SENS
- Stock Information
- Founded
- KMDA 1990
- SENS 1996
- Country
- KMDA Israel
- SENS United States
- Employees
- KMDA N/A
- SENS N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- SENS Industrial Machinery/Components
- Sector
- KMDA Health Care
- SENS Industrials
- Exchange
- KMDA Nasdaq
- SENS Nasdaq
- Market Cap
- KMDA 398.5M
- SENS 360.5M
- IPO Year
- KMDA N/A
- SENS N/A
- Fundamental
- Price
- KMDA $6.95
- SENS $7.20
- Analyst Decision
- KMDA Strong Buy
- SENS Strong Buy
- Analyst Count
- KMDA 2
- SENS 6
- Target Price
- KMDA $13.00
- SENS $28.67
- AVG Volume (30 Days)
- KMDA 77.7K
- SENS 707.8K
- Earning Date
- KMDA 11-12-2025
- SENS 11-05-2025
- Dividend Yield
- KMDA 2.88%
- SENS N/A
- EPS Growth
- KMDA 27.97
- SENS N/A
- EPS
- KMDA 0.32
- SENS N/A
- Revenue
- KMDA $169,517,000.00
- SENS $25,466,000.00
- Revenue This Year
- KMDA $14.49
- SENS $62.96
- Revenue Next Year
- KMDA $10.12
- SENS $72.62
- P/E Ratio
- KMDA $21.01
- SENS N/A
- Revenue Growth
- KMDA 9.67
- SENS 5.94
- 52 Week Low
- KMDA $5.43
- SENS $5.00
- 52 Week High
- KMDA $9.16
- SENS $28.00
- Technical
- Relative Strength Index (RSI)
- KMDA 52.44
- SENS 77.91
- Support Level
- KMDA $6.72
- SENS $6.56
- Resistance Level
- KMDA $7.11
- SENS $7.56
- Average True Range (ATR)
- KMDA 0.19
- SENS 0.44
- MACD
- KMDA 0.03
- SENS 0.62
- Stochastic Oscillator
- KMDA 60.68
- SENS 81.62
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.